CADL: Prakiraan konsensus analis Candel Therapeutics Inc.

Candel Therapeutics (CADL) is developing viral tumor therapies, relying on long-term treatment courses to ensure stable revenue. The company is implementing ESG standards by reducing laboratory waste and adhering to bioethics. Anticipation of the new vaccine test results at the current price of 21.67 confirms the price action chart on GURU.Markets, which has already priced in clinical stage risks.

CADL (Candel Therapeutics, Inc.) riwayat Bagan rega target saka 04.07.2022 nganti 22.10.2026

Rincian analitis perusahaan Candel Therapeutics (CADL)

Indikator analitis utama candeltx.com (CADL):

Kutipan saham candeltx.com|CADL - Prakiraan konsensus analis|Kapitalisasi pasar Candel

Analisis fundamental perusahaan:Candel Therapeutics Inc. (CADL)

Produk asli Candel Therapeutics

The lack of revenue and high capital burn rate associated with the development of oncolytic vaccines at Candel Therapeutics (CADL) make the stock price extremely sensitive to clinical trial results. The history of expert consensus estimates reflects a weighted average target price calculated by investment banks via discounted cash flow analysis, where any sharp fluctuations in the curve signal a revision of the market's fundamental expectations regarding the success of the drugs.

Perusahaan pesaing

Target konsensus beigene.com ONC|Prakiraan konsensus analis HALO (Halozyme)|Prakiraan konsensus analis Revolution Medicines Inc RVMD|Ascentage - Prakiraan konsensus analis|CGON (CG Oncology Therapeutics) - Prakiraan gabungan firma investasi|UroGen Pharma Ltd. (URGN) - Bagan rega target|BCAX (bicara.com) - Bagan rega target|PSNL (Personalis) - Prakiraan konsensus analis|Target konsensus Erasca Inc (ERAS)|Prakiraan konsensus analis DCTH|Prakiraan konsensus analis Y-mAbs Corp (YMAB)|Bagan rega target Aura Biosciences, Inc. AURA|ARAY: Prakiraan gabungan firma investasi|SELLAS Life Sciences Group Inc. - Prakiraan konsensus analis|Actuate Therapeutics Inc. (ACTU) - Target konsensus|CTOR: Prakiraan konsensus analis|Rata-rata rega prakiraan TuHURA Biosciences (HURA)|Bagan rega target Protara Therapeutics|FATE: Konsensus nilai wajar|Target konsensus WHWK (Aadi Bioscience Inc)|TCRX (tscan.com) - Konsensus nilai wajar|Prakiraan konsensus analis CSBR (Champions Oncology, Inc.)|XBIT - Target konsensus|CVM: Target konsensus|OSTX - Prakiraan konsensus analis|Radiopharm Theranostics Limited (RADX) - Bagan rega target|Artiva Biotherapeutics - Konsensus nilai wajar|ANL (Adlai Nortye Ltd) - Prakiraan konsensus analis|Rata-rata rega prakiraan Veru Corporation VERU|Prakiraan konsensus analis TPST|Target konsensus xiliotx.com XLO|Prakiraan konsensus analis RENB (Renovaro)|Prakiraan konsensus analis Mural Oncology PLC MURA|KAPA - Bagan rega target|OKUR (OnKure Therapeutics Inc) - Prakiraan gabungan firma investasi|GDTC: Prakiraan konsensus analis|Prakiraan gabungan firma investasi CRIS|APLM (Apollomics Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan Tharimmune Inc THAR|Bagan rega target Advanced Biomed Inc (ADVB)|Bagan rega target GNPX (Genprex Inc)|Calidi Biotherapeutics, Inc. - Target konsensus|Konsensus nilai wajar SBFM|XBIO: Target konsensus|Salarius Pharmaceuticals Inc - Rega prakiraan analis|PPBT: Prakiraan konsensus analis|American Oncology Network, Inc. - Konsensus nilai wajar|BGNE (BeiGene, Ltd.) - Prakiraan konsensus analis|Rata-rata rega prakiraan checkpointtx.com CKPT|Bagan rega target Elevation Oncology, Inc. (ELEV)|ICAD (icadmed.com) - Konsensus nilai wajar|Prakiraan konsensus analis IKNA (Ikena Oncology)|Prakiraan konsensus analis Notable Labs Corp NTBL|VIRX - Bagan rega target|Bagan tingkat prakiraan MOR|NAYA: Prakiraan konsensus analis|Rata-rata rega prakiraan Ascentage Pharma Group International (AAPGV)